Navigation Links
Utilizing Public Relation Strategies During Pharmaceutical Lifecycle Management for Greatest Impact on Brand and Consumer Base
Date:12/12/2011

CHAPEL HILL, N.C., Dec. 12, 2011 /PRNewswire/ -- Public Relations tactics and tools are broad-reaching, affecting millions of consumers when successful. This makes Public Relations a highly leveraged marketing investment, requiring relatively low investment to reach large audiences. More specifically, Public Relations tools can be easily utilized to benefit all phases of the product lifecycle, especially at launch and brand-building years.

However, field research suggests few companies maximize the full potential of PR campaigns throughout the entire product lifecycle – from preparing and launching to growing and extending a brand, according to Best Practices, LLC study, "Using Public Relations to Launch, Grow and Extend Your Brands."

While Public Relations have long been used as a marketing tool by the pharmaceutical and biotechnology industries, its ability to reach consumers has never been greater. This research will help companies take advantage of the many recommendations and actions to better align PR activities and tactics during the different stages of a product's lifecycle.

Public Relations can also help build a bridge from between a first-generation success to a future blockbuster. Field findings revealed that successor product teams generally should commence Public Relations two years prior to the new product's global launch.

Study topics include:

  • Public relations tools and tactics that are most effective at different lifecycle stages
  • The most effective public relations tools and calls-to-action
  • Successful web site resources for consumers
  • Ideal budget ratios and performance measurements
  • Lessons learned and best practices

The full 108-page report contains over 600 benchmark metrics and more than 35 best practices, delivering insights into the most effective Public Relations channels, tactics and calls-to-action for reaching consumers of pharmaceutical products provided by 18 top biopharmaceutical companies.

Specifically, this research document identifies which Public Relations activities most effectively educate and inform consumers at different points in a product's lifecycle. In addition, this study provides leaders with insights into performance measurements for PR campaigns and what web-based resources best engage patients.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http:/www.best-in-class.com/rr1085.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. For more information about Best Practices, LLC visit our Web site at www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
2. New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis
3. nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure
4. Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
5. Life Spine® Announces Completion of Surgeries Utilizing OCTAVE™ Posterior Fusion System
6. iCyt Unveils Exciting New Flow Cytometry Reagents Utilizing Innovative Fluorochrome Technology
7. Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT®
8. Ambry Genetics Announces Launch of Their CancerArray™ Product and Services Utilizing aCGH Technology
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
11. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... , February 17, 2017 ... the S&P 500 edged lower at the closing bell, ... streak above the 20,000 benchmark. Moreover, five out of ... Taking into consideration yesterday,s market sentiment, Stock-Callers.com assessed the ... & Nephew PLC (NYSE: SNN ), ABIOMED ...
(Date:2/16/2017)... Research and Markets has announced the ... Technologies" report to their offering. ... Traditional medical devices include ... non-drug coated implantables, large endoscopes, needle based drug delivery, lab ... last two to three decades for the treatment and management ...
(Date:2/16/2017)... -- The global preparative and process chromatography market is ... USD 5.49 billion in 2016, at a CAGR of ... the preparative and process chromatography market is segmented into ... chromatography segment is expected to account for the largest ... in this segment can primarily be attributed to the ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across ... Driven in large part by the Hospital Readmission Reduction Program (HRRP), the return of ... focus area for hospitals across the nation. While many providers are struggling to leverage ...
(Date:2/17/2017)... ... 17, 2017 , ... The Mason Pasquin Agency, a Virginia-based ... owners in and around the Hampton Roads metropolitan region, is joining the local ... domestic violence. , There are multiple categories of domestic violence – physical abuse ...
(Date:2/16/2017)... ... February 17, 2017 , ... Harsha ... 10 years of research, development and clinical trials, the founder of Chigurupati Technologies ... patented compound of FDA approved ingredients that when infused into alcohol, protect the ...
(Date:2/16/2017)... ... 17, 2017 , ... Teaching nursing care of vulnerable children is the focus ... is being created with the support of the Hearst Foundations. An initiative of the ... address what has been identified as a critical gap in preparing the next generation ...
(Date:2/16/2017)... Mt. Kisco, New York (PRWEB) , ... February ... ... Westchester Hospital’s (NWH) nursing professionalism, teamwork and superiority in patient care, NWH ... Chair of the Commission on Magnet on Tuesday, January 31, 2017. The American ...
Breaking Medicine News(10 mins):